New insider activity at American Well ( (AMWL) ) has taken place on September 4, 2025.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Intl. President Phyllis Gotlib recently sold 4,781 shares of American Well stock, amounting to a total transaction value of $32,415.
Recent Updates on AMWL stock
American Well Corporation’s recent developments include significant strategic wins and challenges as highlighted in their Q2 earnings call. The company reported a 47% year-over-year growth in software revenue, driven by strategic client deployments, and a notable improvement in adjusted EBITDA, showcasing effective cost management. A major strategic win was securing a contract with Florida Blue, enhancing their healthcare sector reach. However, challenges arose with the Military Health System contract extension, which excluded behavioral health and automated care programs due to budget constraints, impacting revenue guidance. This led to a revision of their 2025 revenue guidance from $250-260 million to $245-250 million. Despite these challenges, the company’s focus on cost reduction and strategic partnerships suggests a cautiously optimistic outlook. TD Cowen adjusted their price target for Amwell, citing the reduced scope of the DHA extension as a key factor.
Spark’s Take on AMWL Stock
According to Spark, TipRanks’ AI Analyst, AMWL is a Neutral.
American Well’s overall stock score is driven by significant financial challenges, including declining revenues and persistent losses. While the earnings call provided some positive insights with improved EBITDA and strategic wins, technical indicators and valuation remain weak, reflecting ongoing operational and market challenges.
To see Spark’s full report on AMWL stock, click here.
More about American Well
YTD Price Performance: -1.14%
Average Trading Volume: 53,792
Technical Sentiment Signal: Sell
Current Market Cap: $109M